Anna-Leena Vuorinen

14PUBLICATIONS
70CO-AUTHORS
NeurogeneticsMajor global burdens of diseaseEpigenetics (incl. genome methylation and epigenomics)Query processing and optimisationCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 07, 2026
Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.

Johannes R Lemke, Andrea Eoli, Ilona Krey

|Dec 09, 2025
Unraveling the Factors Associated With Digital Health Intervention Uptake: Cross-Sectional Study.

Ilona Ruotsalainen, Mikko Valtanen, Riikka Kärsämä

|Oct 14, 2025
GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.

Johannes R Lemke, Andrea Eoli, Ilona Krey

|Sep 10, 2025
User journeys in cross-European secondary use of health data: insights ahead of the European Health Data Space.

Rachel B Forster, Eva Garcia Alvarez, Adrian G Zucco

|May 10, 2023
CYP3A4*22 may increase bleeding risk in ticagrelor users.

Hilkka Liedes, Juha Pajula, Anna-Leena Vuorinen

|Dec 16, 2022
Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis.

Jaakko Lähteenmäki, Anna-Leena Vuorinen, Mika Lehto

Pageof 3

Frequent Collaborators

5 joint publications

Jaakko Lähteenmäki

4 joint publications

Mark van Gils

3 joint publications

Mika Lehto

3 joint publications

Mikko Niemi